Sign In
Buy RHHBY
$51.57
+2.51 (+5.12%)
At Close: Jun 04, 2026
3 Great Foreign Companies to Invest in Right Now
08:15am, Monday, 08'th Jan 2024
ASML dominates an incredibly valuable niche in the semiconductor supply chain. Pharmaceutical giant Roche sports an impressive product pipeline and attractive valuation.
Roche (RHHBY) to Acquire LumiraDx's Point of Care Technology
11:16am, Tuesday, 02'nd Jan 2024
Roche (RHHBY) is set to acquire LumiraDx's Point of Care technology for $295 million and an additional payment of up to $55 million.
Roche to buy part of LumiraDx diagnostics platform for $295 million
06:24pm, Friday, 29'th Dec 2023
Swiss drugmaker Roche said on Friday it has agreed to buy LumiraDx's Point of Care diagnostics platform business for about $295 million.
Your New Year's Resolution For 2024: Invest $10,000 In These 5 Stocks
02:54pm, Friday, 29'th Dec 2023
I review the stocks of five world-class companies that I am convinced will bring me closer to my ambitious goal of being able to fund my living expenses through dividends.
Weighing Their Chances: 5 Leading Healthcare Companies Fight for Market Share in the $100 Billion Weight-Loss Industry
09:45am, Thursday, 21'st Dec 2023
The anti-obesity drug market could be a significant growth opportunity for healthcare companies. Eli Lilly and Novo Nordisk are the big names in the market today, but there could soon be others.
Roche's (RHHBY) sBLA for Xolair Gets FDA Priority Review Tag
12:46pm, Wednesday, 20'th Dec 2023
The FDA accepts and grants priority review to Roche's (RHHBY) supplemental biologics license application for Xolair for the reduction of food allergic reactions. A decision is due in the first quarter
Five obesity-drug trends to watch in 2024: Who can compete with Eli Lilly and Novo Nordisk?
11:17am, Wednesday, 20'th Dec 2023
The obesity drugs that powered huge investor gains in 2023 are poised to inspire more corporate dealmaking, scientific breakthroughs and better patient access in the year ahead, analysts say.
LLY Down as Patients Regain Weight After Stopping Zepbound
03:02pm, Tuesday, 12'th Dec 2023
Full results from a late-stage study show that patients who stopped taking Eli Lilly's (LLY) weight-loss drug for over a year slowly started to regain their lost weight.
Roche (RHHBY) Breast Cancer Drug Meets Primary Goal in Phase III
03:02pm, Tuesday, 05'th Dec 2023
Roche's (RHHBY) phase III study evaluating inavolisib in combination with advanced hormone receptor-positive, HER2-negative breast cancer with a PIK3CA mutation achieves its primary goal.
Small-Cap Russell Leads the Way, Jobs Data to Come
07:32pm, Monday, 04'th Dec 2023
Only the small-cap Russell 2000 managed to stay above zero the entire trading day.
Roche Buys Carmot Therapeutics to Compete in Booming Market for Weight-Loss Drugs
03:20pm, Monday, 04'th Dec 2023
Roche Holding AG is the latest drug maker trying to take advantage of the booming demand for weight-loss drugs.
Roche Will Buy Obesity And Diabetes Drugmaker Carmot Therapeutics In $2.7 Billion Deal
02:24pm, Monday, 04'th Dec 2023
Roche said Carmot Therapeutics' research and development portfolio “has great potential to treat obesity, diabetes and potentially other diseases” both on its own and in combination with Roche's a
Roche (RHHBY) to Acquire Obesity Drug Maker Carmot for $2.7B
01:32pm, Monday, 04'th Dec 2023
Roche (RHHBY) aims to enter the promising and much-in-demand obesity drug market with the acquisition of Carmot Therapeutics, Inc. for $2.7 billion.
Roche to acquire obesity drugmaker Carmot Therapeutics for up to US$3.1B
01:08pm, Monday, 04'th Dec 2023
Roche is expanding its obesity drug pipeline with the acquisition of Carmot Therapeutics for up to US$3.1 billion. Per the agreement, Roche will pay US$2.7 billion upfront to acquire private biotechno
Roche targets oral obesity drugs with Carmot takeover
11:51am, Monday, 04'th Dec 2023
Teresa Graham, CEO of Roche Pharmaceuticals, says its takeover of anti obesity drug developer Carmot Therapeutics will bolster the company's weight-loss treatments, including via potential oral pills.
